Sharda Cropchem Valuation
Is 538666 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 6/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 538666?
Other financial metrics that can be useful for relative valuation.
|What is 538666's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 538666's PE Ratio compare to its peers?
|538666 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
ASTEC Astec LifeSciences
500355 Rallis India
543331 Meghmani Organics
507717 Dhanuka Agritech
538666 Sharda Cropchem
Price-To-Earnings vs Peers: 538666 is good value based on its Price-To-Earnings Ratio (12x) compared to the peer average (22.4x).
Price to Earnings Ratio vs Industry
How does 538666's PE Ratio compare vs other companies in the IN Chemicals Industry?
Price-To-Earnings vs Industry: 538666 is good value based on its Price-To-Earnings Ratio (12x) compared to the Indian Chemicals industry average (19.3x)
Price to Earnings Ratio vs Fair Ratio
What is 538666's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||12x|
|Fair PE Ratio||20.6x|
Price-To-Earnings vs Fair Ratio: 538666 is good value based on its Price-To-Earnings Ratio (12x) compared to the estimated Fair Price-To-Earnings Ratio (20.6x).
Share Price vs Fair Value
What is the Fair Price of 538666 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 538666 (₹442.9) is trading below our estimate of fair value (₹1038.44)
Significantly Below Fair Value: 538666 is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.